Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
On the evening of June 22, Tongrentang (sh600085, share price of RMB 51.17, market value of RMB 70.178 billion) announced that Tongrentang Technology (hk01666, share price of HK $6.02, market value of HK $7.71 billion), a holding subsidiary of the company, would transfer its 49% equity of Beijing Tongrentang second traditional Chinese medicine hospital Co., Ltd. (Tongrentang second traditional Chinese medicine hospital) Beijing Tongrentang South Third Ring Middle Road drugstore Co., Ltd. (South Third Ring Middle Road drugstore) sold 49% of its equity to the related party Beijing Tongrentang medical care industry Investment Group Co., Ltd. (Tongrentang medical care), with the transfer prices of RMB 42.0112 million and 19.3763 million respectively.
This text is a result of machine translation.
Briefing Sep 26, 2022 09:27 PM
· Healthcare
Intracardiac Echocardiography Enterprise, Cardioacc, Wins Angel Round Financing
Briefing Sep 21, 2022 10:38 AM
· Healthcare
Weiyou Gene Nets Tens of Millions of CNY in Series Pre-A Round
In-depth
Healthcare
Immunotherapy in China: A Rising Star in the Field of Cancer Treatment
Immunotherapy is emerging as a powerful weapon in fighting cancer by restarting and maintaining the cancer-immunity cycle to identify, control and eliminate tumor cells rather than killing them directly.
Nov 24, 2022 06:29 PM
Briefing Sep 16, 2022 11:10 PM
· Healthcare
NaviSeed Nets Tens of millions of CNY in Angel Round
Briefing Sep 13, 2022 05:30 PM
· Healthcare
Nuwacell Nets Hundreds of Mns of CNY in Series A
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Sep 09, 2022 04:12 PM
· Healthcare
Trulive Nets Hundreds of Mns of CNY in pre-Series B Financing Round
Briefing Sep 05, 2022 04:50 PM
· Healthcare
LinkZill Nets Tens of Millions of CNY in pre-Series A+
Briefing Aug 31, 2022 08:30 PM
· Healthcare
Enitiatebio Nets One Hundred Million of CNY in Series A Round
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
Briefing Jun 28, 2022 04:29 PM
· Healthcare
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Briefing Jun 28, 2022 10:08 AM
· Healthcare
Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy
Briefing Jun 28, 2022 09:57 AM
· Healthcare
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Insight
Healthcare
Challenges and Opportunities Possessed by Digital Therapeutics Industry
Following the digital therapeutics series report, this article is centered on the challenges and opportunities faced by the digital therapeutics industry and aims to provide insights on the two above aspects.
Nov 23, 2022 03:23 PM
Briefing Jun 28, 2022 09:56 AM
· Healthcare
And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research
Briefing Jun 28, 2022 09:54 AM
· Healthcare
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
Briefing Jun 28, 2022 09:50 AM
· Healthcare
It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results
Briefing Jun 28, 2022 09:37 AM
· Healthcare
Aibo biology: cooperate with Jiahe biology to jointly develop tumor mRNA drugs
See more
Read next
Insight
In-depth
Insight
In-depth
Healthcare
Immunotherapy in China: A Rising Star in the Field of Cancer Treatment
Nov 24, 2022 06:29 PM
Insight
In-depth
Healthcare
Challenges and Opportunities Possessed by Digital Therapeutics Industry
Nov 23, 2022 03:23 PM